Fragmentomics of Epstein-Barr Virus DNA in Plasma Predicts Cancer Risk

Major Finding: Fragmentomics analysis of Epstein-Barr virus DNA in plasma predicts risk of nasopharyngeal carcinoma.Concept: The quantity, size distribution, methylation patterns, and end motifs of plasma DNA alter cancer risk.Impact: Fragmentomics analysis of plasma DNA in the context of virus-associated cancers may have clinical implications for cancer screening.

Publication Details

Journal: Cancer Discovery
Published: 2025-01-01
DOI: https://doi.org/10.1158/2159-8290.cd-rw2025-028
Primary Topic: Viral-associated cancers and disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Fragmentomics of Epstein-Barr Virus DNA in Plasma Predicts Cancer Risk

Jan 1, 2025

Cancer Discovery

Viral-associated cancers and disorders

article

Fragmentomics of Epstein-Barr Virus DNA in Plasma Predicts Cancer Risk

January 1, 2025article en

Abstract

Cancer Discovery

Good health and well-being

Openalex Percentile: Top 93%

Viral-associated cancers and disorders

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Fragmentomics of Epstein-Barr Virus DNA in Plasma Predicts Cancer Risk · Cancer Discovery (2025) | TGRS Research Map | TGRS